FDA approves generic drugs for type 2 diabetes by Aurobindo

02/17/2013 | Pharmaceutical Business Review Online

Aurobindo Pharma received FDA approval to market its pioglitazone tablets in three strengths and its pioglitazone hydrochloride and metformin hydrochloride tablets in two doses. Both drugs are indicated as added therapy, alongside exercise and diet, to assist with glycemic control in patients with type 2 diabetes.

View Full Article in:

Pharmaceutical Business Review Online

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ